Advertisement

Topics

Gene Therapy Systems (GTS) Company Profile

21:03 EDT 21st September 2017 | BioPortfolio

Gene Therapy Systems, Inc. (GTS) designs, develops and commercializes gene therapy products along with other molecular biological reagents for scientists specializing in gene therapy research. GTS is the only company in the biotechnology reagent business that primarily focuses on gene therapy related products.

Location

10190 Telesis Court
San Diego
CA
92121
United States of America

Contact

Phone: (858)-457-1919
Fax: 858-623-9494 or 858-558-3617
Email: kmasri@geneTherapysystems.com


News Articles [3608 Associated News Articles listed on BioPortfolio]

[Comment] Gene therapy for -mediated inherited retinal dystrophy completes phase 3

The eye is an attractive organ for gene therapy because of the small amount of tissue that needs to be transfected, surgical accessibility for gene delivery, and the inbuilt control of the second eye....

How Does the New ‘Gene-Altering’ Therapy Fight Cancer? – Live Science

Live ScienceHow Does the New 'Gene-Altering' Therapy Fight Cancer?Live ScienceA new type of cancer treatment that involves altering a person's genes — and could save children's lives — passed a ma...

Bubble boy hope: Strimvelis gene therapy revises genetic make-up, offers rare immune deficiency cure

First-ever cancer gene therapy approved by FDA

(Alliance for Cancer Gene Therapy) Today's FDA approval of the first-ever CAR T gene therapy for cancer, kymriah, and its orgins.

Gene Therapy Reimbursement: Is Blindness A Bad First Test?

The first gene therapy approval could be coming soon – followed shortly by the first ever gene therapy coverage decision...   

Gene Therapy for Vision Loss

Spark Therapeutics is poised to bring the first gene therapy for an inherited disorder to market in the United States. In May, the company completed its rolling biologics license application submissio...

FDA approval brings first gene therapy to the U.S.

The FDA issued a historic action making the first gene therapy available in the United States, ushering in a new approach to the treatment of cancer and other serious and life-threatening diseases. Th...

Bluebird Bio’s Gene Therapy for Blood Disorders Yields Some Impressive Results — But Also Raises Questions

(STAT News) – The field of gene therapy is making significant strides towards the day when a one-time treatment ? inserting a healthy gene into patients ? could cure a host of inherited, often ...

PubMed Articles [8252 Associated PubMed Articles listed on BioPortfolio]

Future prospects for gene delivery systems.

Gene therapy is the challenging area of biotechnology. Despite its promise for critical diseases, it has serious safety and efficiency issues, particularly with regards to gene transfer systems. Areas...

Systemic tumor-targeted sodium iodide symporter (NIS) gene therapy of hepatocellular carcinoma mediated by B6 peptide polyplexes.

Non-viral polymer-based gene transfer represents an adaptable system for tumor-targeted gene therapy, as various design strategies of shuttle systems together with the mechanistic concept of active tu...

Nanoparticles for siRNA-Based Gene Silencing in Tumor Therapy.

Gene silencing through RNA interference (RNAi) has emerged as a potential strategy in manipulating cancer causing genes by complementary base-pairing mechanism. Small interfering RNA (siRNA) is an imp...

The Tetracycline Responsive System.

Constitutive gene expression is not always the appropriate expression system because the unphysiological levels of expressed protein could be detrimental in studies examining biological roles of prote...

"My Whole Life is Ethics!" Ordinary Ethics and Gene Therapy Clinical Trials.

What and where is ethics in gene therapy? Historical debates have identified a set of ethical issues with the field, and current regulatory systems presume a discrete ethics that can be achieved or pr...

Clinical Trials [3722 Associated Clinical Trials listed on BioPortfolio]

Gene Therapy in Treating Patients With Cancer of The Liver

RATIONALE: Inserting the p53 gene into a person's tumor may improve the body's ability to fight liver cancer. PURPOSE: Phase I trial to study the effectiveness of gene therapy with the p5...

Phase I Study of Ex Vivo Liver-Directed Gene Therapy for Familial Hypercholesterolemia

OBJECTIVES: I. Develop an approach for treating patients with homozygous familial hypercholesterolemia using gene therapy with autologous hepatocytes transduced with a normal low-density...

Gene Therapy in Treating Patients With Recurrent Malignant Gliomas

RATIONALE: Inserting the gene for adenovirus p53 into a person's tumor may improve the body's ability to fight cancer. PURPOSE: Phase I trial to study the effectiveness of gene therapy in...

Gene Therapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer

RATIONALE: Inserting the gene for p53 into a person's cancer cells may improve the body's ability to fight cancer. Radiation therapy uses high-energy x-rays to damage tumor cells. PURPOSE...

Gene Therapy for SCID-X1 Using a Self Lentiviral Vector

This is a Phase I/II clinical trial of gene therapy for X-linked severe combined immunodeficiency (SCID-X1) using a self lentiviral vector to replace the defective genes with good genes. T...

Companies [2523 Associated Companies listed on BioPortfolio]

Gene Therapy Systems (GTS)

Gene Therapy Systems, Inc. (GTS) designs, develops and commercializes gene therapy products along with other molecular biological reagents for scientists specializing in gene therapy research. GTS is ...

Karolinska Institute

The primary objectives of the European Society of Gene Therapy (ESGT) are to promote basic and clinical research in gene therapy, to promote education and the exchange of information and technology re...

Dimension Therapeutics

Dimension Therapeutics is a gene therapy company focused on developing novel therapies to treat rare diseases. Launched by Fidelity Biosciences in 2013, the Dimension team compris...

Neurologix

Neurologix, Inc., a leader in the development of innovative therapies for the brain and central nervous system, utilizes gene therapy and other novel technologies. The central nervous system ("CNS") i...

MOLOGEN AG

MOLOGEN is specializing in selected areas of Molecular Medicine. Our areas of competence are gene expression, gene therapy and bioinformatics. We are dedicated to the development of DNA expression and...

More Information about "Gene Therapy Systems (GTS)" on BioPortfolio

We have published hundreds of Gene Therapy Systems (GTS) news stories on BioPortfolio along with dozens of Gene Therapy Systems (GTS) Clinical Trials and PubMed Articles about Gene Therapy Systems (GTS) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Gene Therapy Systems (GTS) Companies in our database. You can also find out about relevant Gene Therapy Systems (GTS) Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Gene Therapy
Gene therapy is the use of DNA as a pharmaceutical agent to treat disease. It derives its name from the idea that DNA can be used to supplement or alter genes within an individual's cells as a therapy to treat disease. The most common form of gene th...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...


Corporate Database Quicklinks



Searches Linking to this Company Record